MCID: PLC002
MIFTS: 36

Plica Syndrome

Categories: Bone diseases

Aliases & Classifications for Plica Syndrome

MalaCards integrated aliases for Plica Syndrome:

Name: Plica Syndrome 12 15 71
Synovitis 43

Classifications:



External Ids:

Disease Ontology 12 DOID:12225
ICD9CM 34 727.83
MeSH 43 D013585
ICD10 32 M67.5
UMLS 71 C0878705

Summaries for Plica Syndrome

MalaCards based summary : Plica Syndrome, also known as synovitis, is related to tendinitis and pigmented villonodular synovitis. An important gene associated with Plica Syndrome is PES1 (Pescadillo Ribosomal Biogenesis Factor 1). The drugs Etanercept and Prednisolone phosphate have been mentioned in the context of this disorder. Affiliated tissues include bone, t cells and bone marrow.

Wikipedia : 74 Plica syndrome is a condition that occurs when a plica (a vestigial extension of the protective synovial... more...

Related Diseases for Plica Syndrome

Diseases related to Plica Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 413)
# Related Disease Score Top Affiliating Genes
1 tendinitis 29.5 PES1 MMP3
2 pigmented villonodular synovitis 12.9
3 villonodular synovitis 12.6
4 remitting seronegative symmetrical synovitis with pitting edema 12.6
5 talo-patello-scaphoid osteolysis, synovitis, and short fourth metacarpals 12.4
6 gonococcal synovitis 12.3
7 blau syndrome 12.1
8 noonan syndrome 1 12.0
9 sapho syndrome 11.9
10 camptodactyly-arthropathy-coxa vara-pericarditis syndrome 11.8
11 rheumatoid arthritis 11.6
12 legg-calve-perthes disease 11.6
13 tenosynovial giant cell tumor 11.6
14 intermittent hydrarthrosis 11.5
15 noonan syndrome 4 11.5
16 eosinophilic fasciitis 11.5
17 jaccoud's syndrome 11.2
18 osteoarthritis 10.8
19 arthropathy 10.7
20 bone inflammation disease 10.7
21 tenosynovitis 10.7
22 neurofibromatosis, type ii 10.7
23 arthritis 10.7
24 hyperostosis 10.7
25 septic arthritis 10.6
26 psoriatic arthritis 10.6
27 osteomyelitis 10.6
28 temporal arteritis 10.5
29 juvenile rheumatoid arthritis 10.5
30 inflammatory spondylopathy 10.5
31 spondylitis 10.5
32 hemophilia 10.5
33 gout 10.5
34 enthesopathy 10.5
35 frozen shoulder 10.5
36 bursitis 10.5
37 spondyloarthropathy 1 10.4
38 juvenile arthritis 10.4
39 autoimmune disease 10.3
40 reactive arthritis 10.3
41 synovial chondromatosis 10.3
42 osteoid osteoma 10.3
43 chondrocalcinosis 10.3
44 proteasome-associated autoinflammatory syndrome 1 10.3
45 sarcoidosis 1 10.3
46 osteonecrosis 10.3
47 pustulosis of palm and sole 10.3
48 psoriasis 10.3
49 de quervain disease 10.3
50 calcific tendinitis 10.3

Graphical network of the top 20 diseases related to Plica Syndrome:



Diseases related to Plica Syndrome

Symptoms & Phenotypes for Plica Syndrome

Drugs & Therapeutics for Plica Syndrome

Drugs for Plica Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 166)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Etanercept Approved, Investigational Phase 4 185243-69-0
2
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
3
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
4
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
5
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
6 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
7
Infliximab Approved Phase 4 170277-31-3
8
Clotrimazole Approved, Vet_approved Phase 4 23593-75-1 2812
9
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
10
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
11
Cobalt Approved, Experimental Phase 4 7440-48-4 104729
12
Chromium Approved Phase 4 7440-47-3 27668
13
Vitamin D3 Approved, Nutraceutical Phase 4 67-97-0 5280795 6221
14
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4 1406-16-2
15
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
16 Pharmaceutical Solutions Phase 4
17 Vitamins Phase 4
18 Hormones Phase 4
19 Methylprednisolone Acetate Phase 4
20 Respiratory System Agents Phase 4
21 Anti-Asthmatic Agents Phase 4
22 Cyclosporins Phase 4
23 Antifungal Agents Phase 4
24 Anti-Infective Agents Phase 4
25 Calcineurin Inhibitors Phase 4
26 Calciferol Phase 4
27 Adrenocorticotropic Hormone Phase 4
28 Melanocyte-Stimulating Hormones Phase 4
29 beta-Endorphin Phase 4
30 Calcium, Dietary Phase 4
31 Trace Elements Phase 4
32
Nickel Phase 4 7440-02-0 934
33 Nutrients Phase 4
34 Micronutrients Phase 4
35
Calcium Nutraceutical Phase 4 7440-70-2 271
36
Abatacept Approved Phase 3 332348-12-6 10237
37
Leflunomide Approved, Investigational Phase 3 75706-12-6 3899
38
Prednisone Approved, Vet_approved Phase 3 53-03-2 5865
39
Hydroxychloroquine Approved Phase 3 118-42-3 3652
40
Sulfasalazine Approved Phase 3 599-79-1 5353980 5359476
41
Certolizumab pegol Approved Phase 3 428863-50-7
42
Colchicine Approved Phase 3 64-86-8 2833 6167
43
Zoledronic Acid Approved Phase 3 118072-93-8 68740
44
Sargramostim Approved, Investigational Phase 3 83869-56-1, 123774-72-1
45
Lidocaine Approved, Vet_approved Phase 3 137-58-6 3676
46
Ketorolac Approved Phase 3 66635-83-4, 74103-06-3 3826
47
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3 1177-87-3
48
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
49
Chondroitin Phase 3 9007-27-6 53477707
50 Interleukin 1 Receptor Antagonist Protein Phase 3

Interventional clinical trials:

(show top 50) (show all 168)
# Name Status NCT ID Phase Drugs
1 Dosing of Intra-articular Triamcinolone Hexacetonide for Knee Synovitis in Chronic Polyarthritis Unknown status NCT02437461 Phase 4 Triamcinolone hexacetonide
2 Targeting Synovitis in Early Rheumatoid Arthritis (TaSER). Intensive Management of Early Rheumatoid Arthritis Using Either Clinical or Musculoskeletal Ultrasound Assessment of Synovitis − a Randomised Study With Blinded Outcome Assessments Unknown status NCT00920478 Phase 4
3 Remission Induction in Very Early Rheumatoid Arthritis: a Comparison of Etanercept Plus Methotrexate Plus Steroid With Standard Therapy Unknown status NCT00523692 Phase 4 Etanercept, methotrexate and depomedrone;depemedrone
4 A Randomized, Double-blind Study to Evaluate the Efficacy of Iguratimod Versus Placebo in Patients With Rheumatoid Arthritis on Magnetic Resonance Imaging (MRI) Unknown status NCT01893151 Phase 4 Iguratimod;Iguratimod placebo
5 The Comparative Study of Safety and Effectiveness of Intra-articular Injection of Tocilizumab and Compound Betamethasone in Rheumatoid Arthritis of the Knee Unknown status NCT03215407 Phase 4 Intra-articular Tocilizumab;Intra-articular Compound Betamethasone
6 Phase IV Study of Early RA: a Randomized Magnetic Resonance Imaging Study Comparing the Effects of Methotrexate Alone or in Combination With Infliximab or Intravenous Pulse Methylprednisolone Completed NCT00396747 Phase 4 Infliximab, methylprednisolone, methotrexate;Methotrexate;Methotrexate + Methylprednisolone;Methotrexate + Infliximab
7 Combination Treatment With Methotrexate and Cyclosporine in Early Rheumatoid Arthritis. Completed NCT00209859 Phase 4 Methotrexate;Intraarticular betamethasone;Cyclosporine/placebo-cyclosporine
8 Pilot Study to Evaluate the Effect of Mabthera in Combination With MTX in the Inhibition of Progression of Synovitis, Bone Marrow Edema, and Erosions Evaluated by Magnetic Resonance Imaging (MRI) in the Hand of Patients With Rheumatoid Arthritis. Completed NCT00502853 Phase 4 rituximab [MabThera/Rituxan];Methotrexate
9 Phase 4 Study of Low Dose Prednisolone for Knee Osteoarthritis Completed NCT01619163 Phase 4 Placebo;Prednisolone
10 Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab Completed NCT01717859 Phase 4 Tocilizumab
11 Study of The Effect of Corticotrophin in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients From a Clinical and Structural Perspective As Measured by a Clinical Disease Activity Index Score and Bone Edema, Synovitis and Erosions on Magnetic Resonance Imaging Completed NCT01948388 Phase 4 corticotrophin 80 units
12 A Randomized, Double-blind, Placebo-controlled Study to Assess Efficacy of Tocilizumab+Non-biological DMARD in Reducing Synovitis as Measured by MRI at 12 Weeks After Initiation of Treatment in Patients With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Non-biological DMARDs Completed NCT01034397 Phase 4 tocilizumab [RoActemra/Actemra];placebo;non-biological DMARDs
13 Aiming for Remission in Rheumatoid Arthritis: a Randomized Trial Examining the Benefit of Ultrasonography in a Clinical TIght Control Regimen Completed NCT01205854 Phase 4
14 A Multicentre Randomised Trial Of Etanercept And Methotrexate To Induce Remission In Early Inflammatory Arthritis Completed NCT01303874 Phase 4 Etanercept (ETN);Placebo
15 Randomized Clinical Evaluation of Bone Mineral Density Changes Under Non-cemented Trabecular Metal Tibial Component and Cemented Titanium Controls. Completed NCT01764984 Phase 4
16 Can Bone Erosions Heal in Adalimumab (Humira) Treated Rheumatoid Arthritis Patients. An Imaging Study Using Computed Tomography and Magnetic Resonance Imaging. Completed NCT00696059 Phase 4 Adalimumab (Humira)
17 Randomized, Double-blind, Placebo-controlled Trial to Measure the Efficacy and Safety of Vitamin D3 in Patients With Fibromyalgia. Completed NCT03369379 Phase 4 D3 Vitamin
18 Use of Acthar in Rheumatoid Arthritis Related Flares Recruiting NCT02541955 Phase 4 Acthar
19 Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS) Active, not recruiting NCT03419650 Phase 4 ACTHar
20 Serum Calprotectin Level in Patients With Rheumatoid Arthritis and Osteoarthritis Not yet recruiting NCT04201886 Phase 4
21 Adipose Derived Stromal Cell Transplantation as an Adjunct to Arthroscopy in Treatment of Effusion Synovitis of the Early Degenerative Knee Not yet recruiting NCT03922490 Phase 4
22 Effect of Nickel Sensitivity on Patient Reported Outcomes After Total Knee Arthroplasty Not yet recruiting NCT04058743 Phase 4
23 Open Label Study to Describe the Effect of Tocilizumab in Combination With MTX in the Evolution of Articular Damage (Synovitis/Osteitis and Erosions) Evaluated by MRI in the Hand of Patients With Moderate to Severe Rheumatoid Arthritis (RA) and Inadequate Response to Non-biological DMARDs Withdrawn NCT01878318 Phase 4 methotrexate;tocilizumab [RoActemra/Actemra]
24 Multicentre Canadian Study to Measure the Safety and Efficacy of Synoviorthesis Performed With Yttrium-90 or Rhenium-186 Sulfide Unknown status NCT01615991 Phase 3 Radiosynoviorthesis
25 Ultrasound Scores as Imaging Biomarkers of Early Response to Subcutaneous Tocilizumab in Association With Methotrexate in Very Early Rheumatoid Arthritis (TOVERA) Unknown status NCT02837146 Phase 3 Methotrexate (MTX)
26 A Phase 3, Multicenter, Randomized, Open, Prospective, Controlled, Parallel Group Study of Reduction of Therapy in Patients With Rheumatoid Arthritis in Ongoing Remission. Unknown status NCT02779114 Phase 3 Control group
27 Study of the Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee Completed NCT00604539 Phase 3 Chondroitin sulphate (Condrosan);Placebo
28 Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study for Evaluation of Efficacy and Safety of Etanercept Versus Intra-Articular Steroid Injection in Acute Synovitis Completed NCT00522184 Phase 3
29 The Effect of Certolizumab Pegol in Combination With Methotrexate on MRI Synovitis and Bone Edema and Patient Reported Outcomes as Measured Using an Automated Visit Manager System in Moderate to Severe Rheumatoid Arthritis Patients Completed NCT01213017 Phase 3 certolizumab pegol
30 A Phase IIIB Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Assess Short-term Changes in Synovitis and Structural Damage Outcomes in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate, Treated With Abatacept Versus Placebo on a Background Therapy With Methotrexate Completed NCT00420199 Phase 3 Abatacept;Placebo
31 An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve LDA or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective When Treating to Target Completed NCT02566967 Phase 3 tofacitinib
32 A 16-week Double-blind, Placebo-controlled (for Initial 2 Weeks) Randomized Period, Followed by a 24-week Open-label Extension to Assess Magnetic Resonance Image (MRI) - Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA) Completed NCT01235598 Phase 3
33 Open Label, Multicentric Phase IIIb Study to Evaluate the Effect of Tocilizumab in Combination With DMARDs in the Inhibition of Progression of Synovitis, Bone Marrow Edema, and Erosions Evaluated by Dedicated Magnetic Resonance Imaging (MRI) in the Hand of Patients With Rheumatoid Arthritis (RA) Completed NCT00996606 Phase 3 DMARDs;Tocilizumab
34 DOES ETANERCEPT INFLUENCE TWEAK MODULATION OF INFLAMMATION DURING INFLAMMATORY RHEUMATISMS (PSORIATIC ARTHRITIS AND RHEUMATOID ARTHRITIS)? Completed NCT02164214 Phase 3 etanercept Treatment
35 A Randomized Placebo-Controlled Study of the Efficacy and Safety of Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever Completed NCT01705756 Phase 3 Kineret
36 Evaluation of Rituximab in Systemic Sclerosis Associated Polyarthritis Completed NCT01748084 Phase 2, Phase 3 Rituximab;Placebo (NaCl)
37 A 52-week, Multicenter Study to Assess the Time Course of Response to Secukinumab on Joint Inflammation Using Power Doppler Ultrasonography in Patients With Active Psoriatic Arthritis Recruiting NCT02662985 Phase 3 AIN457 (secukinumab);Placebo
38 A Randomized Placebo Controlled Trial Testing The Effect of Zoledronic Acid on Hip Osteoarthritis Recruiting NCT04303026 Phase 3 Zoledronic Acid;Saline 0.9%
39 A Double-blind, Randomized, Placebo-controlled Phase 3 Study of Orally Administered PLX3397 in Subjects With Pigmented Villonodular Synovitis or Giant Cell Tumor of the Tendon Sheath Active, not recruiting NCT02371369 Phase 3 Pexidartinib;Placebo
40 A Phase 3, Multicenter, 12-Week, Double-Blind and 40-Week Open Label Study to Evaluate the Efficacy and Safety of X0002 Spray in Relief of the Signs and Symptoms of Subjects With Osteoarthritis of the Knee Not yet recruiting NCT03081806 Phase 3 X0002
41 A Double-blinded, Prospective, Randomized, Controlled Trial Comparing Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders Terminated NCT02266433 Phase 3 Ketorolac;Dexamethasone
42 Chronic Non-bacterial Osteomyelitis Treated With Pamidronate in a Randomised Placebo Controlled Trial Unknown status NCT02594878 Phase 2 Pamidronatdinatrium
43 A Phase II Randomized, Double -Blind, Placebo Controlled Study to Assess Safety, Tolerability and Effect on Tumor Size of MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS) Completed NCT01643850 Phase 2 MCS110;Placebo
44 A Prospective Double-Blinded Clinical Trial Using Apatone®B for Care and Treatment of Proven Non-Infected Symptomatic Postoperative Total Joint Arthroplasties Completed NCT01272830 Phase 2 Placebo;Apatone®B
45 A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis Completed NCT02087904 Phase 2
46 Phase II Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) Completed NCT01261429 Phase 2 Tasigna
47 Evaluation of Inflammatory and Structural Joint Damage in Patients With Psoriasis and Psoriatic Arthritis Treated With Secukinumab: A Phase 2, Single Arm, Single Centre Mode of Action Study (Psoriasis-Arthritis & Bone Program, PSARTROS) Completed NCT02483234 Phase 2 secukinumab
48 Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis: a Placebo Controlled, Single-Blind, Crossover-Trial, With Randomisation of Treatment Sequence Completed NCT00678782 Phase 2 etanercept;placebo
49 Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy Completed NCT00001677 Phase 2 Methotrexate;Fludarabine
50 Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients: A Randomized Double-Blind Controlled Study Completed NCT00506896 Phase 2 intraarticular injection

Search NIH Clinical Center for Plica Syndrome

Cochrane evidence based reviews: synovitis

Genetic Tests for Plica Syndrome

Anatomical Context for Plica Syndrome

MalaCards organs/tissues related to Plica Syndrome:

40
Bone, T Cells, Bone Marrow, Endothelial, Testes, Neutrophil, B Cells

Publications for Plica Syndrome

Articles related to Plica Syndrome:

(show top 50) (show all 10888)
# Title Authors PMID Year
1
Glenohumeral synovitis score predicts early shoulder stiffness following arthroscopic rotator cuff repair. 61
32273668 2020
2
Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema (RS3PE), improved following surgical resection of prostatic carcinoma: A case report. 61
32420039 2020
3
Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years. 61
31630207 2020
4
Alterations of peripheral gene expression in response to lipopolysaccharide-induced synovitis as a model for inflammation in horses. 61
32442811 2020
5
Multiple umbilical cord-derived MSCs administrations attenuate rat osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitis. 61
32455113 2020
6
Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitis. 61
32366522 2020
7
Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis. 61
31821594 2020
8
Contracture and transient receptor potential channel upregulation in the anterior glenohumeral joint capsule of patients with end-stage osteoarthritis. 61
32113865 2020
9
Grading of Ultrasonography in Rheumatoid Arthritis of Wrist and Hand Joints. 61
31980382 2020
10
Encephalomyeloneuritis and arthritis after treatment with immune checkpoint inhibitors. 61
32461353 2020
11
Differential patterns of pathology in and interaction between joint tissues in long-term osteoarthritis with different initiating causes: phenotype matters. 61
32360537 2020
12
Ultrasonographic Involvement of the anterior chest wall in Spondyloarthritis: Factors associated with 5-years structural progression. A prospective study in 58 patients. 61
32147567 2020
13
Upregulated PKM2 in Macrophages Exacerbates Experimental Arthritis via STAT1 Signaling. 61
32503893 2020
14
Blau syndrome: a rare cause of exuberant granulomatous synovitis of the knee. 61
31960075 2020
15
Ultrasound Assessment of Disease Activity Prevents Disease-Modifying Antirheumatic Drug (DMARD) Escalation and May Reduce DMARD-Related Direct Costs in Rheumatoid Arthritis With Fibromyalgia: An Exploratory Study. 61
31958164 2020
16
Inhibition of Fenton reaction is a novel mechanism to explain the therapeutic effect of intra-articular injection of PRP in patients with chronic haemophilic synovitis. 61
32530133 2020
17
Identification of Patient Needs and Preferences in Pigmented Villonodular Synovitis (PVNS) Using a Qualitative Online Bulletin Board Study. 61
32394210 2020
18
Nivolumab-induced synovitis is characterized by florid T cell infiltration and rapid resolution with synovial biopsy-guided therapy. 61
32571993 2020
19
Two-year changes in MRI-features and pain in thumb base osteoarthritis. 61
32558377 2020
20
Characterizing hand and wrist ultrasound pattern in primary Sjögren's syndrome: a case-control study. 61
32072351 2020
21
The impact of a significant weight loss on inflammation assessed on DCE-MRI and static MRI in knee osteoarthritis: a prospective cohort study. 61
32165240 2020
22
Treat-to-target strategies aiming at additional ultrasound remission is associated with better control of disease activity and less flare in rheumatoid arthritis. 61
32514681 2020
23
EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice. 61
32294155 2020
24
The musculoskeletal impairment negatively impacts the quality of life of children and adolescents with psoriasis. 61
32552795 2020
25
Interleukin-1 Blockade in Systemic Juvenile Idiopathic Arthritis. 61
32291603 2020
26
Remission of Rheumatoid Arthritis and Primary Biliary Cholangitis After Treatment With Tocilizumab. 61
32571731 2020
27
Pulp stem cells with hepatocyte growth factor overexpression exhibit dual effects in rheumatoid arthritis. 61
32522231 2020
28
Prevention and cure: The major unmet needs in the management of rheumatoid arthritis. 61
31899021 2020
29
Therapeutic potential of aryl hydrocarbon receptor ligands derived from natural products in rheumatoid arthritis. 61
31811747 2020
30
Differences in musculoskeletal ultrasound findings between RS3PE syndrome and elderly-onset rheumatoid arthritis. 61
32107667 2020
31
Dark as night: Spelunking for spinal solitary fibrous tumors/hemangiopericytomas in the differential of T2 hypointensity. 61
32507710 2020
32
A Case of Non-tuberculosis Mycobacterium Tenosynovitis with Rice Bodies in a Patient with Systemic Lupus Erythematosus. 61
32536648 2020
33
Assessment of knee pain from MR imaging using a convolutional Siamese network. 61
32055951 2020
34
The Role of Musculoskeletal Ultrasound in the Rheumatoid Arthritis Continuum. 61
32562012 2020
35
Association between IL1B polymorphisms and the risk of rheumatoid arthritis. 61
32240943 2020
36
Neutrophil activation identifies patients with active polyarticular gout. 61
32552822 2020
37
Fluoroquinolone exposure in utero did not affect articular cartilage of resulting foals. 61
32479667 2020
38
Synovitis and synovectomy in haemophilia. 61
32490595 2020
39
Management of Pigmented Villonodular Synovitis (PVNS): an Orthopedic Surgeon's Perspective. 61
32494892 2020
40
The basic and translational science year in review: Confucius in the era of Big Data. 61
32238274 2020
41
Ultrasonography Reliability in the Detection of Inflammatory and Structural Abnormalities: An Exercise in Multiple Joints. 61
32568948 2020
42
DendroPrime as an adhesion barrier on fracture fixation plates: an experimental study in rabbits. 61
32558616 2020
43
Cytomorphological spectrum of hand, wrist, and foot lesions at tertiary care center in central India. 61
32559023 2020
44
Applying cascaded convolutional neural network design further enhances automatic scoring of arthritis disease activity on ultrasound images from rheumatoid arthritis patients. 61
32503859 2020
45
The Role of Arthroscopy in Painful Shoulder Arthroplasty: Is Revision Always Necessary? 61
32057984 2020
46
LPS-induced Inflammation Prior to Injury Exacerbates the Development of Post-Traumatic Osteoarthritis in Mice. 61
32564401 2020
47
Efficacy assessment of radiosynoviorthesis on the progression of radiological osteoarthritic features of hip and ankle joint in patients with osteoarthritis and rheumatoid arthritis. 61
32074661 2020
48
Associations Between Radiographic and Ultrasound-Detected Features in Hand Osteoarthritis and Local Pressure Pain Thresholds. 61
31904188 2020
49
Improving the feasibility of MRI in clinically suspect arthralgia for prediction of rheumatoid arthritis by omitting scanning of the feet. 61
31566238 2020
50
Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: A novel target of geniposide to inhibit angiogenesis. 61
32569777 2020

Variations for Plica Syndrome

Expression for Plica Syndrome

Search GEO for disease gene expression data for Plica Syndrome.

Pathways for Plica Syndrome

GO Terms for Plica Syndrome

Molecular functions related to Plica Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 serine-type endopeptidase activity GO:0004252 8.62 PLGLB2 MMP3

Sources for Plica Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....